AKT INHIBITOR MK-2206; ADVANCED SOLID TUMORS; HEPATOCELLULAR-CARCINOMA; FATTY LIVER; NONALCOHOLIC STEATOHEPATITIS; INSULIN SENSITIVITY; CELL-PROLIFERATION; TISSUE HOMEOSTASIS; YAP ONCOPROTEIN; PATHWAY
JOURNAL OF CLINICAL INVESTIGATION, v.128, no.3, pp.1010 - 1025
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.